Tilray Brands' stock performance hinges on the outlook for marijuana reform in the U.S. President Trump is considering rescheduling marijuana, which has investors bullish on Tilray of late. The ...

Tilray reported Q2 2026 financial results after the bell today. The company reported improvements at the top and bottom of the income statement compared to the same period last year. Featuring a net ...

As Canadian cannabis king Tilray Brands, Inc. TLRY prepares to report its fiscal Q2 2026 results on Thursday, the company stands at a crossroads. After years of regulatory stagnation, President Donald ...

Marijuana stocks exploded higher on Friday, December 12, 2025, fueled by reports that President Donald Trump is preparing to issue an executive order directing federal agencies to reclassify marijuana ...

What To Know: This double-digit surge provides a reprieve for investors after a punishing trailing month during which the stock shed nearly 40% of its value following the company's execution of a ...

Tilray Brands is riding a perfect storm of cannabis industry catalysts that sent the stock climbing on Monday, Dec. 15, 2025. The company finds itself at the intersection of Washington policy ...

President Trump signed an executive order, which directed federal agencies to finish the process of rescheduling cannabis to a Schedule III substance. The cannabis sector had experienced a rally over ...

Tilray leads its peers in terms of revenue and total assets. Village Farms leads the pack in terms of stock price increase. SNDL, Canopy Growth, Village Farms, and Tilray have firm US entry strategies ...